Company intelligence / Profile preview

Norbrook

Newry, County Down, United Kingdomnorbrook.com ↗

Ownership: Private
Employees: ~1700
Development stage: Commercial

Overview

Norbrook has a broad commercial portfolio of veterinary pharmaceuticals for both companion and farm animals. Its products include generic and differentiated medicines such as antibiotics (e.g., amoxicillin/clavulanic acid under the brand "Noroclav"), NSAIDs for pain/inflammation ("Loxicom", "Carprieve", "Flunixin"), antiparasitics ("Closamectin"), anesthetics ("Vetofol"), gastric ulcer treatments ("Peptizole") and endocrine therapies ("Thyronorm"). The company’s products are widely used globally with regulatory approvals including FDA authorization for sterile injectables[1][3][5].

Therapeutic areas: EndocrinologyRheumatologyInfectious Diseases
Modalities: Small moleculeBiologic
Industry: Veterinary

Drug pipeline

1 asset

felanorm

Commercial

Indications: Hyperthyroidism

Partnerships

Not specifically disclosed

Beyond the preview

Go deeper on Norbrook.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Norbrook.